Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1999
10/07/1999CA2325564A1 Inducible alphaviral gene expression system
10/07/1999CA2325017A1 Collagen peptides and uses thereof
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324511A1 Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999CA2324492A1 Secreted proteins and polynucleotides encoding them
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324445A1 Blk genes, gene products and uses thereof in apoptosis
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2324286A1 Growth differentiation factor-9 regulatory sequences and uses therefor
10/07/1999CA2324229A1 Chimeric insecticidal protein and gene coding therefore
10/07/1999CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/07/1999CA2323836A1 Novel sequence class of genes, corresponding proteins and the use of the same
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323524A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999CA2321179A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
10/07/1999CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999EP0947582A1 A polypeptide structure for use as a scaffold
10/06/1999EP0947525A1 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
10/06/1999EP0947524A1 Novel peptides for the treatment of autoimmune diseases
10/06/1999EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999EP0946747A2 Probes, methods and kits for detection and typing of helicobacter pylori nucleic acids in biological samples
10/06/1999EP0946742A1 Chimeric adenoviral vectors
10/06/1999EP0946740A1 Novel constructs and vectors for the targeted and inducible expression of genes
10/06/1999EP0946739A1 Antifungal polypeptide and methods for controlling plant pathogenic fungi
10/06/1999EP0946738A1 Binary methods of increasing accumulation of essential amino acids in seeds
10/06/1999EP0946737A2 Herbicide resistant plants
10/06/1999EP0946736A1 Method for expression of heterologous proteins in yeast
10/06/1999EP0946735A1 N-terminally extended proteins expressed in yeast
10/06/1999EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999EP0946731A1 Non-m non-o hiv strains, fragments and applications
10/06/1999EP0946730A2 Mutants of streptococcal toxin c and methods of use
10/06/1999EP0946729A2 Proteins with enhanced levels of essential amino acids
10/06/1999EP0946728A1 Bone stimulating factor
10/06/1999EP0946727A1 Antibody mutants
10/06/1999EP0946726A2 A variant human alpha-7 acetylcholine receptor subunit, and methods of production and use thereof
10/06/1999EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/06/1999EP0946723A1 Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946721A1 Human growth gene and short stature gene region
10/06/1999EP0946720A2 Neurogenin
10/06/1999EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999EP0946716A1 Waxy wheat starch types having waxy proteins in granule
10/06/1999EP0946715A1 Modified protein c and methods of use thereof
10/06/1999EP0946714A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
10/06/1999EP0946712A1 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
10/06/1999EP0946596A1 Peptide derivatives
10/06/1999EP0946595A2 Melanocortins
10/06/1999EP0946594A2 Enteric neural peptide
10/06/1999EP0946593A1 Use of polypeptides for treating thrombocytopenia
10/06/1999EP0946592A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/06/1999EP0946591A2 Cloned glucagon-like peptide-2 receptors
10/06/1999EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins
10/06/1999EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
10/06/1999EP0946200A1 Immunization of infants
10/06/1999EP0946198A2 Stabilized conjugates of uncomplexed subunits of multimeric proteins
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946191A1 Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity
10/06/1999EP0946188A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
10/06/1999EP0946138A2 Use of a potentilla erecta extract in the cosmetic and pharmaceutical field
10/06/1999EP0779933A4 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
10/06/1999EP0726951B1 Manufacture and use of polypeptides tagged using binding molecules
10/06/1999EP0601108B1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects
10/06/1999CN1230994A Deformylation of f-MET peptides in bacterial expression system
10/06/1999CN1230993A Expression vectors, cells, and methods for preparing thrombopoietin polypeptides
10/06/1999CN1230992A Recombinant plant cells expressing heterochromatin 1 (HP1) of drosophila melanogaster
10/06/1999CN1230991A Hamster EF-1 'alpha' transcriptional regulatory DNA
10/06/1999CN1230967A Process for producing plasma protein-containing medicament
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999CN1230892A Use of proteins as agents against autoimmune diseases
10/06/1999CN1230592A Cotton curve leaf disease virus promoter and its application
10/06/1999CN1230549A Escape mutant of surface antigen of hepatitis B virus
10/06/1999CN1230436A Soluble recombined human bone formation protein 2 used in treating hemospoietic dysfunction and function damage
10/05/1999US5962769 Induction of male sterility in plants by expression of high levels of avidin
10/05/1999US5962669 Nucleic acid encoding prion protein variant
10/05/1999US5962664 Psychosis protecting nucleic acid, peptides, compositions and method of use
10/05/1999US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999US5962652 Antibodies to protein, FAF1
10/05/1999US5962651 Modified hemoglobin and its use as a component of an artificial blood substitute
10/05/1999US5962649 Heating culture medium containing cells to deactivate protease, preferentially adsorbing albumin by contacting with particles suspended in fluidized bed, then eluting and futher purifying albumin
10/05/1999US5962648 Human procollagen or collagen produced in this manner can be made of a single collagen type uncontaminated by other human or non-human collagens.
10/05/1999US5962647 Bovine interleukin-1β protein and amino acid sequence
10/05/1999US5962645 Antiproliferative factor from patients with interstitial cystitis
10/05/1999US5962644 Porcine CD34
10/05/1999US5962643 Integrin β subunit and uses thereof
10/05/1999US5962639 Synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites
10/05/1999US5962636 Peptides capable of modulating inflammatory heart disease
10/05/1999US5962635 Therapeutic compounds
10/05/1999US5962634 Peptide of 6 to 25 amino acids which modulates immunoglobulin e binding to fc epsilon receptor 1; for treatment and prophylaxis of graft vs host disease, allergic rhinitis, food allergies, atropic dermatitis, and allergic asthma
10/05/1999US5962633 There is a need in the art for inhibitors of cysteins proteases as these enzymes have been implicated in the formation of new foci of metastatic carcinoma.
10/05/1999US5962430 Analog of Haemophilus Hin47 with reduced protease activity
10/05/1999US5962428 Compositions and methods for delivery of genetic material
10/05/1999US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999US5962424 Inducing selectin expression using ionizing radiation
10/05/1999US5962420 Wound healing agents; drug delivery; crosslinking fibrin
10/05/1999US5962418 Factor VII-derived peptides